Publications by authors named "Nandini Mehra"

Article Synopsis
  • AI-ECG can effectively detect hypertrophic cardiomyopathy (HCM) and track treatment responses using 12-lead ECGs.
  • The study analyzed data from patients undergoing surgical reduction and those receiving mavacamten at multiple healthcare centers, finding no improvement in HCM scores after surgery, but a significant decrease in scores among patients taking mavacamten.
  • This highlights AI-ECG's potential for ongoing monitoring of heart condition improvements following medication rather than surgical interventions.
View Article and Find Full Text PDF

Background: Pregnant patients with single ventricle (SV) physiology carry a high risk of spontaneous pregnancy loss (SPL), yet the clinical factors contributing to this risk are not well defined.

Methods: Single-centre retrospective study of pregnant patients with SV physiology seen in cardio-obstetrics clinic over the past 20 years with chart review of their obstetric history. Patients without a known pregnancy outcome were excluded.

View Article and Find Full Text PDF

Background: Partial anomalous pulmonary venous return (PAPVR) can be surgically corrected using a pericardial baffle. This baffle can become obstructed post-surgery, leading to pulmonary hypertension and right heart dysfunction if not detected and corrected.

Case Summary: We describe three patients with occluded PAPVR baffles who underwent drug-coated balloon angioplasty and stenting of the obstructed baffle.

View Article and Find Full Text PDF
Article Synopsis
  • Artificial intelligence-enhanced electrocardiography (AI-ECG) can detect hypertrophic cardiomyopathy (HCM) and monitor treatment responses through ECGs, presenting a modern alternative to surgical options like septal reduction therapy (SRT) and oral treatments like mavacamten.
  • A study involving patients from multiple health systems showed no significant change in AI-ECG HCM scores after SRT, indicating that this surgical method may not effectively improve HCM scores.
  • In contrast, patients on mavacamten therapy showed a significant decrease in their AI-ECG scores over a median follow-up period, suggesting that AI-ECG could be useful for regularly tracking improvements in HCM
View Article and Find Full Text PDF
Article Synopsis
  • - Hypertrophic cardiomyopathy (HCM) is a heart disease that can look different from person to person and is caused by genes.
  • - One of the main problems with HCM is that part of the heart can get too thick, which can block blood flow.
  • - There haven't been many new medicines for HCM, but now there's a new kind of drug that could help treat the disease better.
View Article and Find Full Text PDF

Introduction: Hypertrophic cardiomyopathy (HCM), a phenotypically variable disorder with a genetic basis, was first described in the late 1800s. Since the discovery of the disease, various medical and surgical treatments have been proposed with surgical treatments proving to be of more benefit than medical in patients with severe symptoms. Although beta blockers, calcium channel blockers, and disopyramide have been used for their negative inotropic effect, the data behind utilization of these medications is weak at best.

View Article and Find Full Text PDF

Hypertrophic cardiomyopathy (HCM) is a genetic condition with multiple different genetic and clinical phenotypes. As awareness for HCM increases, it is important to also be familiar with potential treatment options for the disease. Treatment of HCM can be divided into two different categories, medical and interventional.

View Article and Find Full Text PDF

Introduction: Bioprosthetic aortic valves are increasingly being utilized in a younger population due to improved durability and possibility for future valve-in-valve replacement. This has resulted in a larger population of patients with bioprosthetic aortic valve degeneration requiring re-intervention. Despite no head-to-head comparisons between redo surgical aortic valve replacement (SAVR) and valve-in-valve transcatheter aortic valve replacement (ViV TAVR), observational studies suggest a comparable long-term risk between which led to the incorporation of ViV TAVR to current guidelines.

View Article and Find Full Text PDF

This study aimed to elucidate a potential dose-dependent relation between coffee intake and atrial fibrillation (AF) incidence in a multi-ethnic setting. Previous studies were comprised mainly of White populations, and an exploration of dose dependency is limited. To address these gaps, we analyzed the Multi-Ethnic Study of Atherosclerosis data, a prospective cohort study.

View Article and Find Full Text PDF

Squamous cell carcinoma (SCC) of the penis is a rare cancer in the industrialized countries, including the United States. Risk factors for these cancers include inflammatory conditions as well as infection with the human papilloma virus (HPV). Treatment modalities are based on TNM staging and may include surgical management or chemoradiation.

View Article and Find Full Text PDF

Introduction: The ablation of outflow tract premature ventricular contractions (PVCs) is generally safe and effective. In some patients, successful ablation sites may not correlate with the earliest activation. We sought to evaluate mechanistic and anatomic relevance of the region below the left sinus of Valsalva in variable morphology outflow tract ventricular arrhythmias.

View Article and Find Full Text PDF

Knowledge of relevant cardiac anatomy is crucial in understanding the pathophysiology and treatment of arrhythmias, and helps avoid potential complications in mapping and ablation. This article explores the anatomy, relevant to electrophysiologists, relating to atrial flutter and atrial fibrillation, ventricular tachycardia relating to the outflow tracts as well as endocardial structure, and also epicardial considerations for mapping and ablation.

View Article and Find Full Text PDF

Background Premature coronary artery disease ( CAD ) is common in patients with coarctation of aorta ( COA ), but there are limited data about any direct relationship (or lack thereof) between COA and CAD . We hypothesized that atherosclerotic cardiovascular disease risk factors, rather than COA diagnosis, was the primary determinant of CAD occurrence in patients with COA . Methods and Results This is a retrospective study of 654 COA patients and a control group of 876 patients with valvular pulmonic stenosis and tetralogy of Fallot to determine prevalence and independent risk factors for CAD .

View Article and Find Full Text PDF

Background Patients with tetralogy of Fallot ( TOF ) remain at risk for cardiovascular events despite successful repair. Some of the current risk stratification tools require advanced imaging and invasive studies, and hence are difficult to apply to routine patient care. A recent study showed that QRS fragmentation ( QRS -f) is predictive of mortality in patients with TOF.

View Article and Find Full Text PDF